{"schema_version":"1","generated_at":"2026-11-05T07:17:32.732Z","data_as_of":"2026-11-04","url":"https://www.findmykol.com/kol/myron-cohen","json_url":"https://www.findmykol.com/kol/myron-cohen/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"myron-cohen","name":"Myron Cohen","credential":"MD","title":"J. Herbert Bate Distinguished Professor of Medicine, Microbiology and Immunology, and Epidemiology; Associate Vice Chancellor for Medical Affairs","specialty":"Infectious Disease","specialty_raw":"Infectious Disease","therapeutic_area":"Infectious Disease","therapeutic_areas":["Infectious Disease"],"institution":"University of North Carolina at Chapel Hill School of Medicine","institution_url":"https://www.findmykol.com/institution/university-of-north-carolina-at-chapel-hill-school-of-medicine","city":"Chapel Hill","state":"NC","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1265505093","orcid":"0000-0001-5917-9664","openalex":"A5024262342"},"summary":"Myron Cohen is J. Herbert Bate Distinguished Professor of Medicine, Microbiology and Immunology, and Epidemiology; Associate Vice Chancellor for Medical Affairs at University of North Carolina at Chapel Hill School of Medicine. OpenAlex indexes 741 publications with 56,217 citations (h-index 117); ClinicalTrials.gov lists 4 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Infectious Disease profiles in the FindMyKOL directory.","overview":{"text":"Myron Cohen, MD, is J. Herbert Bate Distinguished Professor of Medicine, Microbiology and Immunology, and Epidemiology at University of North Carolina at Chapel Hill School of Medicine. The public record shows 741 publications with 56,217 citations (h-index 117), centered on HIV/AIDS Research and Interventions, HIV Research and Treatment, HIV/AIDS drug development and treatment. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 6 companies, 15 NIH-funded awards (1989–2026).","bullets":["Most recent indexed publication: 2026 · The Journal of infectious diseases","Top research focus: HIV/AIDS Research and Interventions","4 registered trials on ClinicalTrials.gov","Open Payments reporting from 6 companies"],"generated_at":"2026-11-04"},"focus":{"indications":[{"label":"HIV","therapeutic_area":"Infectious Disease","trials":4,"topics":0,"strength":13},{"label":"HIV Infections","therapeutic_area":"Infectious Disease","trials":4,"topics":0,"strength":12},{"label":"Sepsis / Serious Bacterial","therapeutic_area":"Infectious Disease","trials":0,"topics":0,"strength":1},{"label":"Viral Hepatitis (B/C)","therapeutic_area":"Gastroenterology","trials":0,"topics":0,"strength":1},{"label":"Tuberculosis","therapeutic_area":"Infectious Disease","trials":0,"topics":0,"strength":1},{"label":"Asthma","therapeutic_area":"Respiratory","trials":0,"topics":0,"strength":1},{"label":"COVID-19","therapeutic_area":"Infectious Disease","trials":0,"topics":0,"strength":1}],"research_topics":["HIV/AIDS Research and Interventions","HIV Research and Treatment","HIV/AIDS drug development and treatment","HIV, Drug Use, Sexual Risk","Reproductive tract infections research"],"drugs_studied":{"total":4,"shown":3,"withheld":1,"rows":[{"name":"Apretude","generic":"Cabotegravir","trials":0,"payments":3,"publications":5,"mentions":8},{"name":"EVUSHELD","trials":0,"payments":3,"publications":0,"mentions":3},{"name":"Cabenuva","trials":0,"payments":2,"publications":0,"mentions":2}]},"works_with":{"total":7,"shown":3,"withheld":4,"rows":[{"name":"AstraZeneca Pharmaceuticals LP","trials":0,"payments":9,"mentions":9},{"name":"Gilead Sciences, Inc.","trials":0,"payments":9,"mentions":9},{"name":"Merck Sharp & Dohme LLC","trials":0,"payments":6,"mentions":6}]}},"scholarship":{"works_count":741,"cited_by_count":56217,"h_index":117,"i10_index":431,"pubmed_count":16,"latest_activity_year":2026,"citation_standing":{"top_percent":1,"cohort":"Infectious Disease","method":"https://www.findmykol.com/about#citation-standing"},"source":"works"},"trials":{"count":4,"shown":3,"withheld":1,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT02716675","title":"Evaluating the Safety and Efficacy of the VRC01 Antibody in Reducing Acquisition of HIV-1 Infection Among Men and Transgender Persons Who Have Sex With Men","phase":"PHASE2","status":"COMPLETED","role":"Investigator","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","source_url":"https://clinicaltrials.gov/study/NCT02716675","trial_url":"https://www.findmykol.com/trial/NCT02716675"},{"nct":"NCT02568215","title":"Evaluating the Safety and Efficacy of the VRC01 Antibody in Reducing Acquisition of HIV-1 Infection in Women","phase":"PHASE2","status":"COMPLETED","role":"Investigator","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","source_url":"https://clinicaltrials.gov/study/NCT02568215","trial_url":"https://www.findmykol.com/trial/NCT02568215"},{"nct":"NCT00296660","title":"Acute HIV Infection Observational Study","status":"COMPLETED","role":"Investigator","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","source_url":"https://clinicaltrials.gov/study/NCT00296660","trial_url":"https://www.findmykol.com/trial/NCT00296660"}],"source":"trials"},"payments":{"company_count":6,"program_years":{"first":2022,"last":2025},"rows_total":14,"shown":3,"withheld":11,"rows":[{"payer":"Gilead Sciences, Inc.","program_year":2025,"amount_usd":13362.56,"payment_count":7,"source_url":"https://openpaymentsdata.cms.gov/search?query=1265505093"},{"payer":"ViiV Healthcare Company","program_year":2025,"amount_usd":151.54,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1265505093"},{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2024,"amount_usd":3759,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1265505093"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1265505093","source":"payments"},"funding":{"award_count":15,"fiscal_years":{"first":1989,"last":2026},"rows_total":120,"shown":3,"withheld":117,"rows":[{"project":"UM1AI068619","title":"HIV Prevention Trials Network Leadership and Operations Center","fiscal_year":2026,"amount_usd":10480,"organization":"FAMILY HEALTH INTERNATIONAL","source_url":"https://reporter.nih.gov/quickSearch/UM1AI068619"},{"project":"UM1AI068619","title":"HIV Prevention Trials Network Leadership and Operations Center","fiscal_year":2026,"amount_usd":10480,"organization":"FAMILY HEALTH INTERNATIONAL","source_url":"https://reporter.nih.gov/quickSearch/UM1AI068619"},{"project":"UM1AI068619","title":"HIV Prevention Trials Network Leadership and Operations Center","fiscal_year":2025,"amount_usd":25429673,"organization":"FAMILY HEALTH INTERNATIONAL","source_url":"https://reporter.nih.gov/quickSearch/UM1AI068619"}],"source":"grants"},"congress":{"count":4,"years":{"first":2019,"last":2023},"societies":["ADA","IDSA"],"shown":3,"withheld":1,"rows":[{"title":"1558. Associations between gender identity and solicited adverse events after passive infusion of VRC01 or placebo in HVTN 704/HPTN 085","society":"IDSA","meeting":"IDWeek","year":2023,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1093/ofid/ofad500.1393","source_url":"https://doi.org/10.1093/ofid/ofad500.1393","status":"verified"},{"title":"2896. Oral PrEP Uptake among HVTN 704/HPTN 085 Participants: Implications for the Future of Biomedical HIV Prevention Trials","society":"IDSA","meeting":"IDWeek","year":2023,"role":"co_author","presentation_type":"unknown","contribution_type":"abstract","doi":"https://doi.org/10.1093/ofid/ofad500.167","source_url":"https://doi.org/10.1093/ofid/ofad500.167","status":"verified"},{"title":"1198-P: Prevention of COVID-with Subcutaneous Administration of CAS+IMD in Individuals with Diabetes and Other Risk Factors for Severe Disease","society":"ADA","meeting":"ADA Scientific Sessions","year":2022,"role":"co_author","presentation_type":"poster","contribution_type":"abstract","doi":"https://doi.org/10.2337/db22-1198-p","source_url":"https://doi.org/10.2337/db22-1198-p","status":"verified"}],"source":"congress"},"publications":{"total":16,"shown":5,"withheld":11,"matched_by":"ORCID record, linked to PubMed","recent":[{"title":"VRC01 exerted differential pressure on HIV-1 Env from subtypes B and C that continued in the first weeks post-diagnosis in the AMP trials.","year":2026,"journal":"The Journal of infectious diseases","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42708883/","status":"verified"},{"title":"Prospective HIV RNA screening with long-acting cabotegravir pre-exposure prophylaxis in HPTN 083.","year":2026,"journal":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/42044061/","status":"verified"},{"title":"HIV low-level viraemia: considerations for prevention and treatment in an era of highly effective and durable antiretroviral therapy regimens.","year":2026,"journal":"Journal of the International AIDS Society","types":["Journal Article"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/41733000/","status":"verified"},{"title":"Improving HIV Prevention Among Heterosexual Men Seeking Sexually Transmitted Infection Services in Malawi: Protocol for a Type I Effectiveness-Implementation Hybrid Randomized Controlled Trial of Systems Navigator-Delivered Integrated Prevention Package (HPTN 112-NJIRA Study).","year":2025,"journal":"JMIR research protocols","types":["Journal Article","Clinical Trial Protocol","Research Support, N.I.H., Extramural"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/40531570/","status":"verified"},{"title":"What if We Had a Vaccine that Prevents Neisseria gonorrhoeae? Inspiration, Assumptions, and Aspirations.","year":2025,"journal":"The Journal of infectious diseases","types":["Editorial","Comment"],"source_url":"https://pubmed.ncbi.nlm.nih.gov/38630582/","status":"verified"}],"most_cited":{"total":741,"shown":5,"withheld":736,"rows":[{"title":"Prevention of HIV-1 Infection with Early Antiretroviral Therapy","year":2011,"cited_by_count":6865,"type":"article","source_url":"https://doi.org/10.1056/nejmoa1105243"},{"title":"Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection","year":2008,"cited_by_count":1912,"type":"article","source_url":"https://doi.org/10.1073/pnas.0802203105"},{"title":"Antiretroviral Therapy for the Prevention of HIV-1 Transmission","year":2016,"cited_by_count":1694,"type":"article","source_url":"https://doi.org/10.1056/nejmoa1600693"},{"title":"Sexual Transmission of HIV","year":1997,"cited_by_count":1065,"type":"article","source_url":"https://doi.org/10.1056/nejm199704103361507"},{"title":"Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus","year":2013,"cited_by_count":988,"type":"article","source_url":"https://doi.org/10.1038/nature12053"}]},"source":"publications"},"network":{"coauthors_total":40,"shown":3,"withheld":37,"coauthors":[{"name":"Joseph J. Eron","coauthored_works":78},{"name":"Irving Hoffman","coauthored_works":75},{"name":"William C. Miller","coauthored_works":70}],"source":"works"},"presence":{"owned_accounts":{"total":2,"shown":2,"rows":[{"platform":"other","url":"https://globalhealth.unc.edu/people/myron-cohen-md","status":"verified"},{"platform":"other","url":"https://www.med.unc.edu/cfar/people/myron-cohen","status":"verified"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":4,"shown":4,"rows":[{"value":"Bachelor of Science, University of Illinois Urbana-Champaign","source_url":"https://en.wikipedia.org/wiki/Myron_S._Cohen","status":"verified","collected_at":"2026-11-04"},{"value":"M.D., Rush Medical College","source_url":"https://en.wikipedia.org/wiki/Myron_S._Cohen","status":"verified","collected_at":"2026-11-04"},{"value":"Internal Medicine Residency, University of Michigan","source_url":"https://en.wikipedia.org/wiki/Myron_S._Cohen","status":"verified","collected_at":"2026-11-04"},{"value":"Infectious Disease Fellowship, Yale University","source_url":"https://en.wikipedia.org/wiki/Myron_S._Cohen","status":"verified","collected_at":"2026-11-04"}]},"roles":{"total":5,"shown":3,"rows":[{"value":"Co-chair, National Institutes of Health HIV Prevention Trials Network","source_url":"https://en.wikipedia.org/wiki/Myron_S._Cohen","status":"verified","collected_at":"2026-11-04"},{"value":"Fellow, American College of Physicians","source_url":"https://en.wikipedia.org/wiki/Myron_S._Cohen","status":"verified","collected_at":"2026-11-04"},{"value":"Fellow, Infectious Diseases Society of America","source_url":"https://en.wikipedia.org/wiki/Myron_S._Cohen","status":"verified","collected_at":"2026-11-04"}]},"awards":{"total":6,"shown":3,"rows":[{"value":"2026 Faculty Award for Global Excellence","source_url":"https://www.med.unc.edu/medicine/news/myron-s-cohen-awarded-2026-faculty-faculty-award-for-global-excellence-from-unc-global-affairs/","status":"verified","collected_at":"2026-11-04"},{"value":"Elected Member, Institute of Medicine (2012)","source_url":"https://en.wikipedia.org/wiki/Myron_S._Cohen","status":"verified","collected_at":"2026-11-04"},{"value":"Tar Heel of the Year (2012)","source_url":"https://en.wikipedia.org/wiki/Myron_S._Cohen","status":"provisional","collected_at":"2026-11-04"}]},"secondary_affiliations":{"total":2,"shown":2,"rows":[{"value":"Institute for Global Health and Infectious Diseases, University of North Carolina","source_url":"https://globalhealth.unc.edu/people/myron-cohen/","status":"verified","collected_at":"2026-11-04"},{"value":"Division of Infectious Diseases, UNC School of Medicine","source_url":"https://en.wikipedia.org/wiki/Myron_S._Cohen","status":"verified","collected_at":"2026-11-04"}]},"media":{"total":1,"shown":1,"rows":[{"value":"Science Magazine interview on continuing HIV prevention trials during COVID-19 pandemic","source_url":"https://www.med.unc.edu/medicine/news/cohen-discusses-how-hiv-prevention-trials-continue-during-pandemic","status":"provisional","collected_at":"2026-11-04"}]},"public_positions":{"total":2,"shown":2,"rows":[{"value":"Congressional Briefing, Lifesaving NIH Infectious Disease Research (July 9, 2025)","source_url":"https://www.treatmentactiongroup.org/webinar/congressional-briefing-on-lifesaving-nih-infectious-disease-research/","status":"provisional","collected_at":"2026-11-04"},{"value":"Leadership Role, NIH COVID Prevention Network (CoVPN) - COVID-19 monoclonal antibody prevention research","source_url":"https://www.med.unc.edu/medicine/news/cohen-discusses-how-hiv-prevention-trials-continue-during-pandemic","status":"provisional","collected_at":"2026-11-04"}]}},"similar":[{"name":"Bradley Gaynes","slug":"bradley-gaynes","institution":"University of North Carolina at Chapel Hill School of Medicine","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/bradley-gaynes","json_url":"https://www.findmykol.com/kol/bradley-gaynes/profile.json"},{"name":"Alan Hinderliter","slug":"alan-hinderliter","institution":"University of North Carolina at Chapel Hill School of Medicine","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/alan-hinderliter","json_url":"https://www.findmykol.com/kol/alan-hinderliter/profile.json"},{"name":"Amy Mottl","slug":"amy-mottl","institution":"University of North Carolina at Chapel Hill School of Medicine","specialty":"Nephrology","url":"https://www.findmykol.com/kol/amy-mottl","json_url":"https://www.findmykol.com/kol/amy-mottl/profile.json"},{"name":"Christopher Sayed","slug":"christopher-sayed","institution":"University of North Carolina at Chapel Hill School of Medicine","specialty":"Dermatology","url":"https://www.findmykol.com/kol/christopher-sayed","json_url":"https://www.findmykol.com/kol/christopher-sayed/profile.json"},{"name":"Thomas Walsh","slug":"thomas-walsh","institution":"Cornell University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/thomas-walsh","json_url":"https://www.findmykol.com/kol/thomas-walsh/profile.json"},{"name":"Douglas Richman","slug":"douglas-richman","institution":"University of California San Diego","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/douglas-richman","json_url":"https://www.findmykol.com/kol/douglas-richman/profile.json"},{"name":"Henry Masur","slug":"henry-masur","institution":"National Institutes of Health","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/henry-masur","json_url":"https://www.findmykol.com/kol/henry-masur/profile.json"},{"name":"Vance Fowler","slug":"vance-fowler","institution":"Duke University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/vance-fowler","json_url":"https://www.findmykol.com/kol/vance-fowler/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":1,"payments":11,"funding":117,"congress":1,"publications":11,"network":37}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts","collected_at":"2026-11-04"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-11-04"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2022 to 2025","collected_at":"2026-11-04"},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year","collected_at":"2026-11-04"},"congress":{"name":"OpenAlex","url":"https://openalex.org","provides":"DOI-verified congress abstracts across AACR, ASCO, ASH, ASTRO, ESMO","disclaimer":"Congress abstracts are published as DOI-bearing journal supplements and attributed via the same ORCID-disambiguated authorship as publications.","collected_at":"2026-11-04"},"publications":{"name":"PubMed (NLM)","url":"https://pubmed.ncbi.nlm.nih.gov","provides":"Peer-reviewed publications, linked to the PubMed record","collected_at":"2026-11-04"}},"methodology_url":"https://www.findmykol.com/about#methodology"}